Thursday, February 26, 2026
spot_img
HomeIndustriesHealthcare

Healthcare

RegeneRx Partner Submits Phase 3 Protocol for Neurotrophic Keratopathy (NK)

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...

Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, announced the release of the THUNDERBEAT Open...

Babylon and Bupa extend partnership to deliver digital health services to all Bupa UK health insurance customers

Babylon  and Bupa have announced that they have extended their partnership agreement for a further three years to deliver digital health services to 2.3...

Centers for Medicare & Medicaid Services issues preliminary payment rate determination for Immunovia’s IMMray PanCan-d test

Immunovia AB (NASDAQ Stockholm: IMMNOV) announced, that the Centers for Medicare & Medicaid Services (CMS) published a preliminary payment determination implying a price of...

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...

Hot Topics

spot_img